Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP783787.RAtu6X2YqtVzcq2jo5LaJMMm93xvUnU87dRSi4GGu8Vfk130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP783787.RAtu6X2YqtVzcq2jo5LaJMMm93xvUnU87dRSi4GGu8Vfk130_assertion type Assertion NP783787.RAtu6X2YqtVzcq2jo5LaJMMm93xvUnU87dRSi4GGu8Vfk130_head.
- NP783787.RAtu6X2YqtVzcq2jo5LaJMMm93xvUnU87dRSi4GGu8Vfk130_assertion description "[None (0/22) of normal cervical biopsies, 9% (6/66) of CIN1 lesions, 53% (34/64) of CIN3 lesions, 90% (85/94) of cervical squamous cell carcinomas (SCCs), and 93% (26/28) of cervical adenocarcinomas (AdCAs) demonstrated MAL promoter methylation at both promoter regions.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP783787.RAtu6X2YqtVzcq2jo5LaJMMm93xvUnU87dRSi4GGu8Vfk130_provenance.
- NP783787.RAtu6X2YqtVzcq2jo5LaJMMm93xvUnU87dRSi4GGu8Vfk130_assertion evidence source_evidence_literature NP783787.RAtu6X2YqtVzcq2jo5LaJMMm93xvUnU87dRSi4GGu8Vfk130_provenance.
- NP783787.RAtu6X2YqtVzcq2jo5LaJMMm93xvUnU87dRSi4GGu8Vfk130_assertion SIO_000772 19662663 NP783787.RAtu6X2YqtVzcq2jo5LaJMMm93xvUnU87dRSi4GGu8Vfk130_provenance.
- NP783787.RAtu6X2YqtVzcq2jo5LaJMMm93xvUnU87dRSi4GGu8Vfk130_assertion wasDerivedFrom befree-20140225 NP783787.RAtu6X2YqtVzcq2jo5LaJMMm93xvUnU87dRSi4GGu8Vfk130_provenance.
- NP783787.RAtu6X2YqtVzcq2jo5LaJMMm93xvUnU87dRSi4GGu8Vfk130_assertion wasGeneratedBy ECO_0000203 NP783787.RAtu6X2YqtVzcq2jo5LaJMMm93xvUnU87dRSi4GGu8Vfk130_provenance.